Jefferies is a global, full‑service investment banking and capital markets firm that helps investors, companies, and governments with advisory services, sales and trading, research, and wealth and asset management. It uses a worldwide network of more than 40 offices to deliver market insights and financial solutions to clients. Its products include advisory services for mergers and restructurings, capital markets execution, securities research, and portfolio management for individuals and institutions. The goal is to guide clients through financial markets, raise capital, and grow wealth across geographies and asset classes.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
1854
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
Wellness Program
Jefferies has identified three undervalued biotechnology stocks with strong commercial prospects despite challenging macroeconomic conditions. Delphia Therapeutics' oral psychedelic DT120 has produced three positive Phase III datasets for major depressive disorder and generalized anxiety disorder. Jefferies estimates $1.5 billion or more in peak sales per indication, implying a $9 billion valuation against the current $5 billion market cap. Axsome Therapeutics' Auvelity is approved for major depressive disorder and Alzheimer's agitation. Management's peak sales guidance of $8 billion for Auvelity suggests significant upside. BridgeBio Pharma is positioned to launch four blockbuster oral medications. Attruby could reach $3-4 billion in US peak sales, whilst three additional billion-dollar products will launch in 2027. The firm noted rising interest rates are pressuring small and mid-cap biotech companies, potentially shifting investor focus toward late-stage and commercial-stage names.
Jefferies has named Molbio Diagnostics its top pick in India's medical supplies sector, initiating coverage with a Buy rating and a price target of INR1,600. The brokerage projects revenue compound annual growth rate of 22% and profit after tax CAGR of 47% through FY26-29E. Founded in 2000, Molbio has developed the Truenat platform, an ultra-portable molecular diagnostics system that represents 86% of FY26 sales. The platform, built after 13 years of research, supports testing for 30 diseases and is patent-protected in over 100 countries. Jefferies expects margin expansion of approximately 830 basis points, driven by rising test-kit capacity utilisation and the scaling of Molbio's Optrascan platform to 11% of sales by FY29E.
Jefferies stung by soured bets at asset-management unit. 29 Sep 2026, 09:07 pm (Sept 29): Jefferies Financial Group Inc's asset-management unit revenue slumped more than 50% in the fiscal third quarter, sending shares down as the bank grapples with fallout from tumultuous investments. Net revenue in that business totalled US$85.6 million (RM349 million) in the three months through August, down from almost US$177 million in the same period a year earlier, according to a statement late Monday. That business has been dealing with soured bets on First Brands Group and Radiant World that the firm was exposed to through Leucadia Asset Management's Point Bonita fund. Shares of Jefferies dropped 1.1% in early New York trading, extending this year's decline to more than 25%. "We remain confident in the long-term outlook for the business as we continue to reposition the platform by reducing capital allocated to certain existing funds consistent with the strategy we outlined last fall when we announced our intent to acquire and fund a 50% interest in Hildene," chief executive officer Richard Handler and president Brian Friedman said in the statement. In 2025, Jefferies agreed to buy a 50% stake in Hildene Holding Co, a credit-focused asset manager that the bank had had a strategic relationship with for years. The firm's asset-management woes overshadowed a record quarter for Jefferies' stock traders and investment bankers. Equity-trading revenue surged 29% from a year earlier to US$626 million, boosted by cash and electronic trading as well as the prime services business that works with hedge funds. Revenue at the investment-banking business rose 17% to US$1.3 billion. That was driven by a 25% gain in the advisory unit and a 69% increase in the equity-underwriting business. In recent months, Radiant World has come under scrutiny amid allegations of fraud. Jefferies' exposure to Radiant World was less than US$300 million, Bloomberg previously reported. Fixed income. Jefferies' fixed-income trading business also had a tougher quarter, hit by a sluggish market that drove a 26% decrease in net revenue. Still, equity trading was "robust," even if questions are arising about how sustainable it can be, according to Vital Knowledge's Adam Crisafulli. The quarter was OK, he said. "Not amazing, not horrible." Earnings per share totalled US$1.08 in the period, surpassing the US$1 average estimate of analysts in a Bloomberg survey. Jefferies is the first of the major US banks to post third-quarter results, setting a benchmark for Wall Street firms that report in October. The results offer a look into how investment-banking businesses have held up despite market volatility. "We are very optimistic about the balance of 2026 and our momentum heading into 2027, supported by the breadth and strength of our current backlog and new business activity," Handler and Friedman said in the statement. The bank's quarter is also a positive sign for Wall Street's other equity-trading desks, many of which had already started hinting at how good the quarter was shaping up. Bank of America Corp. CEO Brian Moynihan said equity trading climbed in the quarter through the middle of September, while Goldman Sachs Group Inc's David Solomon said equity trading has remained "very strong." Fixed-income trading, however, has been softer in some parts of Wall Street. Bank of America has cautioned that revenue in the business was down and bouncing around. Uploaded by Magessan Varatharaja
Jefferies surpasses profit estimates on strong dealmaking. Jefferies Financial (JEF.N) has exceeded third-quarter profit estimates, propelled by strong performance in its advisory and stock underwriting businesses. The New York-based investment bank, which advises on deals, underwrites stock sales, and operates trading desks and an asset management business, reported profit attributable to shareholders of $260.6 million, or $1.08 per share, for the three months ended August 31. This comfortably surpassed the average analyst estimate of $1 per share, according to LSEG data. The company's investment banking revenue saw a significant 17% jump, reaching $1.33 billion, underpinned by record advisory business performance and robust equity underwriting. Revenue from its capital markets segment, encompassing Jefferies' trading desks, also climbed 11% to $802 million, driven by record equities trading. These results offer an early indication of broader investment banking trends on Wall Street, arriving ahead of major US banks' earnings reports in coming weeks, and align with a global dealmaking environment that has exceeded $4 trillion this year. Despite the overall strong showing, Jefferies' asset management business faced headwinds. Fees and investment return revenue in this division shrank considerably to $34 million, down from $84 million a year earlier. This decline reflects weaker performance across several fund strategies, notably Point Bonita, which held exposure to the bankrupt auto-parts supplier First Brands. Looking forward, CEO Richard Handler and President Brian Friedman expressed optimism for 2026 and momentum into 2027, citing strong backlog and new business activity, while also affirming confidence in the long-term outlook for the asset management platform. However, the firm's shares were down 1.5% in extended trading, contributing to an approximate 24% decline this year.
Jefferies Financial Group reported third-quarter 2026 net revenues of $2.22 billion, with net earnings attributable to common shareholders of $261 million and diluted earnings per share of $1.08. Return on adjusted tangible shareholders' equity was 13.5%. Investment banking net revenues reached a record $1.33 billion, up 17% year-over-year, driven by a 25% increase in advisory revenues and 69% growth in equity underwriting. Capital markets net revenues rose 11% to $802 million, with equities hitting a quarterly record of $626 million. The company's board declared a quarterly dividend of $0.40 per share and increased the share buyback authorisation to $250 million. During the quarter, Jefferies repurchased 1.3 million shares for $70 million. SMBC has increased its equity ownership in Jefferies to approximately 20%, becoming the largest shareholder.